This information is intended for Colorado Prescribers

HB 19-1131

MARKETED PRESCRIPTION DRUG

COLORADO WAC DISCLOSURE FORM

DATE UPDATED

Diabetes Products

Form

1/4/2023

Vaccines

Form

 1/1/2023

ALDURAZYME® (laronidase)

Form

1/16/2023

ALPROLIX® [Coagulation factor IX (recombinant), Fc fusion protein]

Form

 3/27/2023

ALTUVIIIO® [Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl]

Form

 3/27/2023

AUBAGIO® (teriflunomide)

Form

 1/4/2023

CABLIVI® (caplacizumab-yhdp)

Form

 1/4/2023

CERDELGA® (eliglustat) capsules, for oral use

Form

1/16/2023

Cerezyme® (imiglucerase) for injection

Form

1/19/2022

DUPIXENT® (dupilumab) Injection

Form

 1/4/2023

ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein]

Form

 1/4/2023

ENJAYMO® (sutimlimab-jome) injection, for intravenous use

Form

 1/4/2023

FABRAZYME® (agalsidase beta) for injection, for intravenous use

Form

1/16/2023

JEVTANA® (cabazitaxel) Injection

Form

 1/4/2023

KEVZARA® (sarilumab)

Form

 1/4/2023

LEMTRADA® (alemtuzumab)

Form

 1/4/2023

LOVENOX® (enoxaparin sodium injection) 

Form

7/15/2022

LUMIZYME® (alglucosidase alfa)

Form

1/16/2023

Mozobil® (plerixafor injection)

Form

 1/4/2023

MULTAQ® (dronedarone)

Form

 1/4/2023

NEXVIAZYME® (avalglucosidase alfa-ngpt) for injection, for intravenous use

Form

1/16/2023

REZUROCK® (belumosudil) tablets

Form

 1/4/2023

SARCLISA® (isatuximab-irfc) injection

Form

 1/4/2023

Thymoglobulin® [Anti-thymocyte Globulin (Rabbit)]

Form

 1/4/2023

THYROGEN® (thyrotropin alfa for injection)

Form

1/18/2023

XENPOZYME® (olipudase alfa-rpcp) for injection, for intravenous use

Form

9/9/2022

House Bill 19-1131. Published by the General Assembly of the State of Colorado    

Please See Full Prescribing Information, including Boxed Warning, for Aldurazyme, Aubagio, Jevtana, Kevzara, Lemtrada, Lovenox, Lumizyme, Multaq,
 Nexviazyme, Thymoglobulin , Xenpozyme

MAT-US-2007971-v8.0-3/2023